LMH STRATEGIC SOLUTIONS

Lobbying for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) · Represents and protects the interests of midsized biopharmaceutical innovators.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $230,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical Supply Chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.